Receps Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Receps
Receps Limited (RL) is a Public Limited Indian Non-Government Company incorporated in India on 12 May 2022 (Two years and eight months 22 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Siva Manda, Popuri Krishna, and Eshwar Purmandla serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239TG2022PLC162610
-
Company No.
162610
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
12 May 2022
-
Date of AGM
09 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Receps?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siva Manda
|
Nominee Director | 18-Mar-2024 | Current |
|
Popuri Krishna
|
Director | 05-Nov-2022 | Current |
|
Eshwar Purmandla
|
Director | 05-Nov-2022 | Current |
Financial Performance of Receps.
Receps Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Receps?
In 2023, Receps had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Visakha Pharmacity LimitedSiva Manda, Popuri Krishna and 1 more are mutual person
-
Srinagar Banihal Expressway LimitedEshwar Purmandla is a mutual person
-
Ramky Infrastructure LimitedEshwar Purmandla is a mutual person
-
Apiic Food Park (Krishna District) LimitedSiva Manda is a mutual person
-
Andhra Pradesh Gas Infrastructure Corporation Private LimitedSiva Manda is a mutual person
-
Bhartiya International Sez LimitedSiva Manda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Receps?
Receps has a workforce of 82 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Receps, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Receps's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
